Navigation Links
Simmons Firm's Partner Trent Miracle Chosen to Help Lead National Litigation Against Bayer
Date:11/30/2009

EAST ALTON, Ill., Nov. 30 /PRNewswire/ -- The Simmons law firm's Trent Miracle will serve on a committee dedicated to representing thousands of women that were seriously injured after taking Yaz (Yasmin), the popular birth control pill manufactured and marketed by Bayer Pharmaceuticals.

The U.S. Judicial Panel on Multidistrict Litigation has ordered that all federal Yaz and Yasmin birth control pill lawsuits be consolidated and centralized for pretrial litigation in the Southern District of Illinois under the guidance of U.S. District Judge David R. Herndon in East St. Louis. Miracle is one of 13 attorneys selected to manage the national litigation.

"We anticipate seeing as many as 10,000 cases," said Miracle, who heads up the Simmons firm's pharmaceutical litigation practice. "Unfortunately, the injuries are widespread and serious. Consolidating these lawsuits into multidistrict litigation should allow us to help these women in a manner that's both efficient and fair."

All of the cases involve allegations that the popular birth control pills containing the new progestin drospirenone increase the risk of serious and potentially life-threatening health problems, such as heart attacks, strokes, pulmonary embolisms, deep vein thrombosis, gallbladder disease, and sudden death. The complaints allege that Bayer Pharmaceuticals, which manufactures both Yaz and Yasmin, failed to adequately research their products, fraudulently concealed the risk of injury, negligently failed to warn about the degree of risk women faced, and misrepresented the safety of the drugs in comparison to other available birth control pills.

Miracle said his role on the Steering Committee will be defined in the coming months as he and other attorneys continue to gather evidence against Bayer. Earlier this year Miracle took over the Simmons firm's growing pharmaceutical practice, which already is recognized on the national stage for its groundbreaking litigation of drug and supplement cases against major pharmaceutical companies. Miracle has worked extensively litigating against the development and marketing of dangerous drugs such as Vioxx, Bextra, Ortho Evra, Ephedra and Phenylpropanolamine (PPA), Oxycontin, and others.

"When corporations put profits over safety, the legal system is often the last resort for the people that were hurt," said Miracle. "I look forward to serving on this committee and working hard to represent the interest of thousands of women who were unfairly harmed."

About Simmons Browder Gianaris Angelides & Barnerd LLC

The Simmons firm is a leading national law firm in the fight against mesothelioma. With offices in Illinois and California, the firm has represented thousands of patients and families affected by mesothelioma from all across the country. The Simmons firm is passionate about improving the lives of victims of mesothelioma and asbestos-related illnesses and has pledged over $15 million to cancer research. The firm also has practice areas in intellectual property, pharmaceutical litigation, and business litigation.

SOURCE Simmons Browder Gianaris Angelides & Barnerd LLC


'/>"/>
SOURCE Simmons Browder Gianaris Angelides & Barnerd LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. China-Biotics, Inc. Begins Trial Production at New Facility, Affirms 2010 Revenue Guidance
2. New Study Confirms VASER Lipo Results Are Superior to Standard Liposuction
3. Perrigo Confirms Filing for Generic Version of Mens Rogaine(R) Foam
4. Study Confirms Effectiveness of Innovative Prism Glasses For Hemianopia Patients
5. CVS Caremark Data Confirms Improved Outcomes for Women with Osteoporosis Who are Adherent to Therapy
6. Study Confirms: Your Hidden Food Allergies Are Making You Fat
7. Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R) and Announcement of Lawsuit by Stiefel
8. New Study Confirms That the Supports Intensity Scale Assessment is Effective in Measuring the Support Needs of People With Intellectual Disability and Making Funding Decisions
9. Sosei Confirms the Safety of SD118 in Two Phase I Trials
10. National Study Presented at ACG 2008 Confirms New Device Functions Like Rear-View Mirror to Provide Improved View of the Colon
11. Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... -- According to a study conducted by Persistence Market ... a CAGR of 6.5% during the forecast period 2016-2024. According to ... be the leading market for cryotherapy globally during the forecast period  ... Highlights from the ... and adequate supply of gas in order to provide smoother maintenance ...
(Date:1/19/2017)... , Jan. 19, 2017  Abaxis, Inc. (NasdaqGS: ... blood analysis instruments and consumables for the medical and ... discuss its financial results for the third quarter fiscal ... be at 4:15 p.m. ET on Thursday, January 26, ... third quarter fiscal year 2017 after the market closes ...
(Date:1/19/2017)... Jan. 19, 2017  Sensus Healthcare, Inc. (NASDAQ: ... specializing in the treatment of non-melanoma skin cancers ... superficial radiation therapy, today announced that it will ... financial results on Thursday, February 2, 2017 after the ... a conference call with the investment community on Thursday, ...
Breaking Medicine Technology:
(Date:1/20/2017)... ... ... Bionic Sports Nutrition LLC, an American company devoted to developing high-quality nutritional supplements ... Trade Show in Hilton Head, SC. , Bionic Sports Nutrition manufactures its entire ... to all clients at reasonable prices. At the ECRM trade show, it had a ...
(Date:1/20/2017)... ... January 20, 2017 , ... ATP Science, ... everyday lives, recently attended the January ECRM Trade Show in Hilton Head, SC, ... for its large range of supplements that keep the body functioning at its ...
(Date:1/20/2017)... , ... January 20, 2017 , ... Michael and Betsy ... Farber Cancer Institute. For Betsy, the clinical trial has been life-saving as she ... not worsened. , Betsy Brauser was diagnosed with ovarian cancer in 2009. She ...
(Date:1/20/2017)... York, NY (PRWEB) , ... January 20, 2017 ... ... – VW+ 001 and its sugar-free alternative VW+ 002. The drinks have been ... body with optimal conditions to perform during your workout. , After a successful ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a heartwarming and earnest tale ... each of his children. “The Angel” is the creation of published author, Marjorie Lund-Fontaine, ... City, and impassioned writer. , When asked of her new book, Marjorie says, “‘The ...
Breaking Medicine News(10 mins):